Loading clinical trials...
Loading clinical trials...
OASIS: Observational Study of LAIs In Schizophrenia
Conditions
Locations
57
United States
Alkermes Investigational Site
Tucson, Arizona, United States
Alkermes Investigational Site
Costa Mesa, California, United States
Alkermes Investigational Site
El Cajon, California, United States
Alkermes Investigational Site
Granada Hills, California, United States
Alkermes Investigational Site
Oceanside, California, United States
Alkermes Investigational Site
Panorama City, California, United States
Start Date
March 28, 2019
Primary Completion Date
January 4, 2023
Completion Date
January 4, 2023
Last Updated
February 2, 2023
NCT06894212
NCT06003036
NCT04226898
NCT05240976
NCT05304767
NCT07455929
Lead Sponsor
Alkermes, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions